Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 64 filings·Updated 20 Aug 2026
Showing 10 of 64 filings.
20 Aug 20261 filing
Company UpdateGeneral

Mukka Proteins corrects total consideration for SESPL investment to ₹66.25 lakh

SESPL investment correction

  • Correction to SESPL investment: board approved acquisition for 26,500 shares at ₹250 each.
  • Total consideration corrected to ₹66,25,000; previously disclosed ₹64,92,500.
  • Shareholding post-acquisition remains 25.98%.
  • Number of shares, price per share, and material terms unchanged.
  • Investment size remains cash-based and aligned with Waste Management expansion.
  • Indicative completion deadline: 31-12-2026.
  • SESPL operates waste collection, treatment and disposal; FY2025-26 turnover ₹1,77,61,136.
  • Not a related party transaction.
Filed 15:57View Source
19 Aug 20261 filing
Company UpdateNewspaper Publication

Intimation regarding Newspaper publication of Notice of 16th Annual General Meeting.

Filed 11:52View Source
18 Aug 20262 filings
Company UpdateGeneral

Mukka Proteins dispatches web link for FY2025-26 Annual Report and AGM notice to unregistered email holders

Shareholder communications for unregistered emails

  • Letter to shareholders without registered emails will provide a weblink to access FY2025-26 Annual Report and AGM notice.
  • The 16th AGM is scheduled for 10 September 2026 at 3:00 PM IST via Video Conferencing/OAVM.
  • The Annual Report is available at: https://mukkaproteins.com/wp-content/uploads/2026/08/Annual-Report-2025-26.pdf.
  • Shareholders are urged to register missing KYC details; forms available on Mukka Proteins website and Cameo portal.
  • The notice and annual report will be emailed to registered addresses as on 14 August 2026.
Filed 16:19View Source
AGM/EGMAGM

Mukka Proteins 16th AGM to consider borrowing, RPTs, and director appointments; no dividend proposed

AGM Details

  • 16th AGM scheduled for 10 September 2026 at 3:00 PM via VC/OAVM.
  • Record date 3 September 2026; remote e-voting 7–9 September 2026; voting during AGM.

Dividend

  • Dividend for FY2025-26 has not been recommended.

Key Resolutions

  • Ordinary: Adoption of standalone and Consolidated financial statements for FY2025-26.
  • Ordinary: Re-appointment of Arif (retiring by rotation) as Director.
  • Ordinary: Re-appointment of Umaiyya Banu (retiring by rotation) as Director.
  • Special: Increase borrowing limit under Section 180(1)(c) to Rs 1,000 crore.
  • Special: Creation of mortgage/charge on assets up to Rs 1,000 crore under Section 180(1)(a).
  • Special: Re-appointment of independent directors for a second five-year term (2027–2032).
  • Special: Re-appointment of MD & CEO for five years with defined remuneration.
  • Special: Re-appointment of WTD & CFO for five years with defined remuneration.
  • Special: Re-appointment of WTD & COO for five years with defined remuneration.
  • Special: Related party transactions with AMPL up to Rs 300 crore (Audit Committee approvals).
  • Special: Related party transactions with Progress Frozen & Fish Sterilization up to Rs 300 crore.
  • Special: Related party transactions with Ullal Fish Meal & Oil Company up to Rs 300 crore.
  • Special: Related party transactions with Mangalore Fish Meal & Oil Company up to Rs 300 crore.
  • Other related party approvals and approvals for preferential issue of warrants (if applicable).

Voting Results

  • Voting results for each resolution are not provided in the filing.

Director Changes

  • Directors retiring by rotation proposed for re-appointment: Arif and Umaiyya Banu.
  • Independent Directors Rao, Hamad Bava and Narendra Kamath proposed for re-appointment 2027–2032.
  • Board comprises 3 Executive, 3 Independent, and 2 Non-Executive Directors; several appointments/rotations noted.

Auditor Appointments

  • Statutory auditors: Shah & Taparia (appointed for 5-year term to 2029-30).
  • Secretarial auditors: Chethan Nayak & Associates (5-year term).
  • Internal auditor: Sirajuddin, Chartered Accountant.

Material Related Party Transactions

  • AMPL (Atlantic Marine) – proposed RPT up to Rs 300 crore; AMPL is a subsidiary.
  • Progress Frozen and Fish Sterilization – RPT up to Rs 300 crore; related party.
  • Ullal Fish Meal and Oil Company – RPT up to Rs 300 crore; related party.
  • Mangalore Fish Meal and Oil Company – RPT up to Rs 300 crore; related party.
  • RPTs approved by Audit Committee; pricing at arm’s length; omnibus approvals sought.

Other Material Approvals

  • Preferential issue of up to 2,00,00,000 fully convertible warrants at Rs 23.50 each; Postal Ballot approved 12-Jul-2026.
Filed 15:51View Source
14 Aug 20263 filings
Company UpdateNewspaper Publication

Newspaper publication of intimation of 16th Annual General Meeting.

Filed 12:51View Source
Company UpdateGeneral

Mukka Proteins schedules 16th AGM for FY2025-26 on 10 Sep 2026 via VC/OAVM

AGM details

  • 16th AGM for FY2025-26 scheduled on 10 September 2026 at 3:00 PM IST
  • Meeting to be conducted via Video Conferencing/Other Audio-Visual Means
  • Notice and Annual Report for FY2025-26 will be dispatched later
  • Intimated in compliance with Companies Act 2013 and SEBI LODR
Filed 12:42View Source
Company UpdateNewspaper Publication

Intimation regarding newspaper publication of Q1 FY 27 Financials Results.

Filed 12:34View Source
13 Aug 20262 filings
Company UpdateInvestor Presentation

Q1 FY27 Mukka Proteins: Delta Marine stake, Oman expansion, and robust export-led revenue

Business Overview

  • Integrated animal protein platform with four verticals and waste-to-value focus.
  • Fish Protein, Alternate Proteins, Waste Management, Frozen & Value-added Marine Products.
  • Exports-led model with 25+ countries; 17 owned facilities in India/Oman.
  • Installed capacity 2,91,720 MT/year and 1,400 TPD; MarinTrust-improver programme.

Key Operational Highlights

  • Delta Marine acquisition: 51% stake for ₹11.1 Cr.
  • Customs litigation relief: ₹15.2 Cr demand set aside by CESTAT.
  • Oman expansion: 25.98% stake in Swachha Eco Solutions for ₹64.9 Lakh.
  • Aqua Marine investment: 51% stake up to ₹15 Cr.
  • Upcoming Oman facility Aljoubah: 21,249 sq m; operations expected soon.
  • Bengaluru Leachate Treatment: order ₹474.89 Cr; CAPEX ~₹100 Cr; JV 76%.

Financial Performance

  • Total income FY23–FY26: ₹1,183.80 Cr; ₹1,396.10 Cr; ₹1,021.50 Cr; ₹1,478.20 Cr.
  • Export revenue share stood at 89.5% in Q1 FY27.
  • Total Revenues from operations FY23–FY26: ₹1,177.10 Cr; ₹1,379.80 Cr; ₹1,006.40 Cr; ₹1,449.50 Cr.
  • Profit before tax and profit for the year reflect cyclical cost dynamics across years.

Capital & Liquidity

  • Capacity: 2,91,720 MT/year; 1,400 TPD across operations.
  • Oman operations expansion underway; Aljoubah site supports expansion.
  • Delta Marine: ₹11.1 Cr for 51% stake; Aqua Marine: up to ₹15 Cr for 51%.
  • Bengaluru Leachate CAPEX ~₹100 Cr; order value ₹474.89 Cr.

Strategic Priorities & Outlook

  • Four vertically integrated platforms to drive long-term, scalable growth.
  • Expand in India and Oman; strengthen backward integration and supply chain.
  • Invest in Alternate Proteins (BSF) and waste-to-value assets.
  • Leverage policy tailwinds (e.g., Matsya Sampada) and MarinTrust certification.

Risks & Mitigation

  • Fishmeal supply constraints expected from 2028; Rabobank warnings.
  • Climate change/El Niño could disrupt supply and raise price volatility.
  • Mitigation: diversify across verticals; backward integration; ESG-led supply chain.

Governance & Leadership

  • Founder Chairman: Mr. K Abdul Razak, advisory role.
  • MD & CEO: K. Mohammed Haris; Whole-Time Director & CFO: K. Mohammed Althaf.
  • Whole-Time Director & COO: K. Mohammed Arif; Independent Directors: Balachandra Rao, Kamath, Bava.
  • Company Secretary & Compliance Officer: Mehaboobsab M Chalyal.
Filed 15:14View Source
Company UpdatePress Release / Media Release

Mukka Proteins Reports Strong Q1 FY27 Consolidated Revenue; announces SESPL stake and Delta Marine acquisition

Consolidated performance

  • Consolidated revenue ₹ 4,896.54 Mn; YoY growth 186.7%.
  • Consolidated gross profit ₹ 1,078.00 Mn; gross margin 22.02%.
  • Consolidated EBITDA ₹ 486.23 Mn; EBITDA margin 9.93%.
  • Consolidated PAT ₹ 186.34 Mn; PAT margin 3.81%.

Standalone performance

  • Standalone revenue ₹ 4,058.56 Mn; YoY growth 198.9%.
  • Standalone gross profit ₹ 814.85 Mn; gross margin 20.08%.
  • Standalone EBITDA ₹ 441.36 Mn; EBITDA margin 10.87%.
  • Standalone PAT ₹ 194.07 Mn; PAT margin 4.78%.

Strategic actions and litigation

  • Board approved ₹6.49 Mn for 25.98% Swachha Eco Solutions stake; SESPL becomes associate.
  • Acquired 51% stake in Delta Marine Products for ₹111 Mn.
  • CESTAT set aside roughly ₹152.4 Mn customs demand.

Outlook and priorities

  • Outlook: capacity expansion, operational excellence, product innovation, and market diversification.
Filed 15:06View Source
12 Aug 20261 filing
Company UpdateAcquisition

Mukka Proteins to acquire 25.98% stake in Swaccha Eco Solutions for ₹64,92,500 to expand waste management

Acquisition details

  • Target: Swaccha Eco Solutions Private Limited (SESPL), engaged in waste collection, treatment and disposal in India.
  • Turnover FY2025-26: ₹1,77,61,136.
  • Net worth FY2025-26: ₹(2,10,22,476).
  • PAT FY2025-26: ₹(75,05,051).
  • Not a related party transaction.
  • Industry: waste collection, treatment and disposal.
  • Purpose: strategic investment to expand Mukka's Waste Management segment.
  • Regulatory approvals: Not applicable.
  • Indicative completion by 31-12-2026.
  • Form of consideration: cash for 26,500 equity shares.
  • Acquisition price: ₹64,92,500 for 26,500 shares.
  • Post-acquisition holding: 25.98%.
  • Background: SESPL incorporated 12 Sep 2017; operates in India.
  • Turnover history: 2024 ₹1,44,45,028; 2025 ₹2,77,64,810; 2026 ₹1,77,61,136.
Filed 17:26View Source
Showing 10 of 64 filings